Economics of Malignant Gliomas: A Critical Review-Reference-Cited by-同舟云学术

Economics of Malignant Gliomas: A Critical Review

Published:2015-01 Issue:1 Volume:11 Page:e59-e65
ISSN:1554-7477
Container-title:Journal of Oncology Practice
language:en
Short-container-title:JOP

Author:

Raizer Jeffrey J.¹,Fitzner Karen A.¹,Jacobs Daniel I.¹,Bennett Charles L.¹,Liebling Dustin B.¹,Luu Thanh Ha¹,Trifilio Steven M.¹,Grimm Sean A.¹,Fisher Matthew J.¹,Haleem Meraaj S.¹,Ray Paul S.¹,McKoy Judith M.¹,DeBoer Rebecca¹,Tulas Katrina-Marie E.¹,Deeb Mohammed¹,McKoy June M.¹

Affiliation:

1. Northwestern University Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center, Northwestern University; DePaul University; Rush Medical College; Northwestern Memorial Hospital; University of Chicago, Chicago; Midwestern University, Downers Grove; Northshore University Health Systems, Skokie Hospital, Skokie, IL; Yale School of Public Health, New Haven, CT; and South Carolina Center of Economic Excellence for Medication Safety and Efficacy and the Southern Network on Adverse Reactions,...

Abstract

With increased chemotherapy use for malignant glioma, the paradigm for treatment and associated out-of-pocket and total medical costs continue to evolve.

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Health Policy,Oncology (nursing),Oncology

Link

https://ascopubs.org/doi/pdfdirect/10.1200/JOP.2012.000560

Reference39 articles.

1. Targeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastoma

2. Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma

3. Glioblastoma multiforme: a review of where we have been and where we are going

4. Estimating the Cost of Cancer: Results on the Basis of Claims Data Analyses for Cancer Patients Diagnosed With Seven Types of Cancer During 1999 to 2000

5. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is add-on Bevacizumab therapy to Temozolomide and radiotherapy associated with clinical utility for newly diagnosed Glioblastoma? A systematic review and meta-analysis;Neurosurgical Review;2024-08-20

2. Telehealth Utilization in Neuro-Oncology: Commentary on a Single Institution Experience After the COVID-19 Pandemic;Current Oncology Reports;2024-07-31

3. Pharmaceutical equivalent 5-aminolevulinic acid fluorescence guided resection of central nervous system tumors: feasibility, safeness and cost-benefit considerations;Journal of Neuro-Oncology;2024-05-06

4. Healthcare spending versus mortality in central nervous system cancer: Has anything changed?;Neuro-Oncology Practice;2024-04-27

5. A tale of two tumors: differential, but detrimental, effects of glioblastoma extracellular vesicles (EVs) on normal human brain cells;2024-04-12